Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Furman

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Current Opinion in Hematology|September 1, 1999
Laboratory markers of platelet activation and their clinical significanceA D Michelson, M I Furman
Current Cardiology Reports|September 12, 2000
Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agentsM I Furman, A L Frelinger III, A D Michelson
Circulation|September 26, 2001
Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarctionA D Michelson, M R Barnard, L A Krueger, et al.
Circulation Research|July 1, 1994
Platelet tyrosine kinases and fibrinogen receptor activationM I Furman, D Grigoryev, P F Bray, et al.
Circulation|September 19, 2001
Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregationA L Frelinger, M I Furman, L A Krueger, et al.
Methods (San Diego, Calif.)|June 30, 2000
Evaluation of platelet function by flow cytometryA D Michelson, M R Barnard, L A Krueger, et al.
The American Journal of Cardiology|October 6, 2000
Ten-year trends in the incidence, treatment, and outcome of Q-wave myocardial infarctionH L Dauerman, D Lessard, J Yarzebski, et al.
Journal of the American College of Cardiology|May 10, 2001
Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspectiveM I Furman, H L Dauerman, R J Goldberg, et al.
The American Journal of Cardiology|October 15, 1996
Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarctionM I Furman, R C Becker, J Yarzebski, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
The cleaved peptide of the thrombin receptor is a strong platelet agonistM I Furman, L Liu, S E Benoit, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Current Opinion in Hematology|September 1, 1999
Laboratory markers of platelet activation and their clinical significanceA D Michelson, M I Furman
Current Cardiology Reports|September 12, 2000
Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agentsM I Furman, A L Frelinger III, A D Michelson
Circulation|September 26, 2001
Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarctionA D Michelson, M R Barnard, L A Krueger, et al.
Circulation Research|July 1, 1994
Platelet tyrosine kinases and fibrinogen receptor activationM I Furman, D Grigoryev, P F Bray, et al.
Circulation|September 19, 2001
Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregationA L Frelinger, M I Furman, L A Krueger, et al.
Methods (San Diego, Calif.)|June 30, 2000
Evaluation of platelet function by flow cytometryA D Michelson, M R Barnard, L A Krueger, et al.
The American Journal of Cardiology|October 6, 2000
Ten-year trends in the incidence, treatment, and outcome of Q-wave myocardial infarctionH L Dauerman, D Lessard, J Yarzebski, et al.
Journal of the American College of Cardiology|May 10, 2001
Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspectiveM I Furman, H L Dauerman, R J Goldberg, et al.
The American Journal of Cardiology|October 15, 1996
Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarctionM I Furman, R C Becker, J Yarzebski, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 1998
The cleaved peptide of the thrombin receptor is a strong platelet agonistM I Furman, L Liu, S E Benoit, et al.
Pageof 3